PTG-100
- Generic Name
- PTG-100
PTG-100 for Patients With Celiac Disease
- First Posted Date
- 2020-08-24
- Last Posted Date
- 2022-05-23
- Lead Sponsor
- Nielsen Fernandez-Becker
- Target Recruit Count
- 12
- Registration Number
- NCT04524221
- Locations
- 🇺🇸
Stanford University, Redwood City, California, United States
Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis
- First Posted Date
- 2016-09-09
- Last Posted Date
- 2021-10-22
- Lead Sponsor
- Protagonist Therapeutics, Inc.
- Target Recruit Count
- 98
- Registration Number
- NCT02895100
- Locations
- 🇺🇦
Site Reference ID/Investigator # 547, Zaporizhzhya, Ukraine
🇺🇦Site Reference ID/Investigator # 509, Kharkov, Ukraine
🇺🇸Site Reference ID/Investigator # 101, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath